PubRank

Andrea R Genazzani

Author PubWeight™ 58.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 2003 1.49
2 Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003 1.48
3 Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause 2007 1.47
4 Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol 2006 1.35
5 Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 2002 1.11
6 Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007 1.08
7 Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 2008 1.08
8 Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One 2008 1.08
9 Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol 2013 1.02
10 Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids 2002 0.98
11 Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003 0.97
12 Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer 2010 0.97
13 Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004 0.96
14 Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One 2012 0.95
15 Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab 2008 0.95
16 Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2008 0.95
17 Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod 2008 0.90
18 Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet 2008 0.88
19 P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res 2006 0.87
20 Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003 0.87
21 Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol 2010 0.86
22 Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol 2009 0.86
23 Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology 2002 0.84
24 Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol 2014 0.83
25 Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging 2007 0.83
26 Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest 2002 0.83
27 Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril 2003 0.83
28 Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas 2006 0.82
29 Sex steroids and breast cancer metastasis. Horm Mol Biol Clin Investig 2010 0.82
30 Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas 2005 0.81
31 Effects of oral contraceptives on bone mineral density. Treat Endocrinol 2004 0.81
32 Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol 2002 0.81
33 Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause 2008 0.80
34 Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol 2006 0.80
35 The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol 2013 0.80
36 Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord 2003 0.80
37 Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther 2003 0.80
38 Membrane integrity evaluation in rabbit spermatozoa. Eur J Obstet Gynecol Reprod Biol 2002 0.80
39 Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause 2005 0.80
40 Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas 2012 0.79
41 Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med 2012 0.79
42 Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas 2011 0.79
43 Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas 2005 0.79
44 Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas 2002 0.79
45 One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. Maturitas 2007 0.79
46 Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Gynecol Endocrinol 2011 0.78
47 Paroxetine increases brain-derived neurotrophic factor in postmenopausal women. Menopause 2010 0.78
48 Hormone therapy. Menopause 2003 0.78
49 Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril 2006 0.78
50 Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels. Gynecol Endocrinol 2007 0.78
51 Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas 2005 0.77
52 The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women. Gynecol Endocrinol 2007 0.77
53 A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 2004 0.77
54 Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab 2004 0.77
55 Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. Nat Rev Endocrinol 2012 0.77
56 One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas 2008 0.76
57 Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol 2010 0.76
58 [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives]. Recenti Prog Med 2003 0.76
59 Clinical evaluation of patients with weight loss-related amenorrhea: neuropeptide Y and luteinizing hormone pulsatility. Gynecol Endocrinol 2006 0.76
60 Clinical relevance of the HERS trial. Lancet 2002 0.76
61 Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial. Maturitas 2002 0.76
62 Menopausal hot flashes: still an undiscovered territory. Menopause 2009 0.75
63 Dehydroepiandrosterone, the endothelium, and cardiovascular protection. Endocrinology 2007 0.75
64 Vasomotor symptoms and negative affect: time to act. Menopause 2011 0.75
65 Hard stuff for the bones. Menopause 2012 0.75
66 When hormone therapy sneaks under your nose. Menopause 2008 0.75
67 Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1). Mol Hum Reprod 2012 0.75
68 Raloxifene treatment increases plasma levels of beta-endorphin in postmenopausal women: a randomized, placebo-controlled study. Fertil Steril 2002 0.75
69 Detailed fetal anatomy assessment in the first trimester at 11, 12 and 13 weeks of gestation. J Matern Fetal Neonatal Med 2011 0.75
70 ISGE statement on oral emergency contraception. Gynecol Endocrinol 2014 0.75
71 The fetal brain: role of progesterone and allopregnanolone. Horm Mol Biol Clin Investig 2016 0.75
72 The osteoporosis dilemma. Gynecol Endocrinol 2004 0.75
73 Effect of DHEA therapy on sexual behavior in female rats. Gynecol Endocrinol 2013 0.75
74 The Xmas present for women's health: a strike to osteoporosis prevention. Maturitas 2004 0.75
75 European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens. Gynecol Endocrinol 2015 0.75
76 Pelvic tuberculosis mimicking advanced ovarian cancer. J Minim Invasive Gynecol 2010 0.75
77 Estrogens and women's health: a scary or a fairy tale? Gynecol Endocrinol 2004 0.75
78 Impaired reduction of enhanced levels of dehydroepiandrosterone by oral dexamethasone in anorexia nervosa. Psychoneuroendocrinology 2005 0.75
79 Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules. Mol Hum Reprod 2011 0.75
80 Time is moving fast. Gynecol Endocrinol 2012 0.75
81 Does nuchal translucency thickness in the first trimester predict GDM onset during pregnancy? Gynecol Endocrinol 2010 0.75